NYSE:DGX

Hims & Hers (HIMS) Stock Jumps on Canada Launch and YourBio Deal: Latest News, Forecasts and Analysis for December 4, 2025

Hims & Hers shares jumped about 8% Thursday to $40.19 after announcing a Canada launch, backed by its Livewell acquisition. The company also agreed to buy YourBio Health and recently launched a diagnostics platform with Quest Diagnostics. Market cap stands near $12.8 billion. Short interest remains high, with 67.6 million shares sold short, or about 36% of the float.

4 December 2025

Financial Forecasts·NYSE:DGX·NYSE:HIMS·Stock Market

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health shares fell about 7–8% to $36.05 Friday after launching its new Labs diagnostic platform with Quest Diagnostics. The company’s market cap stands near $8.2 billion. Labs offers nationwide blood testing and health monitoring through annual subscriptions. The stock remains up roughly 43% year-to-date but trades well below its 52-week high.

14 November 2025

NYSE:DGX·NYSE:HIMS·Stock Market

AI Just Diagnosed You—Now What? The Rise of Superhuman Doctors Made of Code

An AI chatbot diagnosed a U.S. boy’s chronic pain as spina bifida occulta after 17 doctors failed; a specialist confirmed the result. Microsoft’s MAI-DxO correctly diagnosed 85% of nearly 300 complex cases, far surpassing physicians. By October 2024, the FDA had cleared over 1,000 AI medical devices, mainly for radiology, but no generative AI system had full approval as a medical device.

29 July 2025

Artificial Intelligence·NASDAQ:GOOGL·NASDAQ:IBM·NASDAQ:MSFT·NYSE:DGX

CAVA Q1 CY2026 Earnings Beat Expectations, Shares Surge
May 19, 2026, 6:02 PM EDT. CAVA (NYSE:CAVA) posted a strong Q1 CY2026 performance with revenue rising 32.1% year-on-year to $438.3 million, surpassing analyst estimates by 4.7%. The Mediterranean fast-casual chain reported GAAP earnings per share of $0.20, a 14% beat over consensus, and adjusted EBITDA of $61.73 million. Same-store sales increased 9.7%, while operating margin improved to 5.8% from 4.7% a year earlier. The company ended the quarter with 459 locations, up from 393. CEO Brett Schulman highlighted CAVA's resilience amid macroeconomic and geopolitical pressures. Market capitalization stands at $9.3 billion. Analysts forecast 20.5% revenue growth for the next 12 months, reflecting confidence in the brand's expansion and menu offerings despite a projected growth slowdown.

POET Stock Just Raised $400 Million — Why Traders Still Hit Sell

20 May 2026

POET Technologies shares fell 8.02% to $13.07 on Tuesday, despite closing a $400 million financing deal with MMCAP International. The company issued over 19 million shares and warrants at $21 per package, aiming to expand production capacity tenfold. POET reported a first-quarter net loss of $12.3 million on $503,389 in revenue. A new $50 million order from Lumilens could scale to $500 million over five years.

Microsoft Shares Slip Again While AI Bulls Confront Rate Jitters

19 May 2026

Microsoft shares fell 1.4% to $417.42 on Tuesday as rising U.S. Treasury yields pressured large tech stocks. The Nasdaq Composite dropped 0.84%. Microsoft’s market value stood at about $3.1 trillion. The company’s India president said its largest data center in the country will open by mid-2026 amid strong demand for Azure and AI tools.

Skillz Stock Jumps 18% as Traders Eye $420 Million Papaya Verdict

19 May 2026

Skillz shares rose 18.2% to $7.80 Tuesday, valuing the company near $120 million. Investors focused on a June court decision after a federal jury ordered Papaya Gaming to pay $420 million in damages for false advertising. Skillz reported a first-quarter net loss of $10.9 million on $29.1 million revenue. The court has not finalized the damages award.

NYSE:DGX 29 July 2025 - 4 December 2025